| DNA repair systems as targets of cadmium toxicity C Giaginis, E Gatzidou, S Theocharis Toxicology and applied pharmacology 213 (3), 282-290, 2006 | 252 | 2006 |
| Current clinical status on the preventive effects of cranberry consumption against urinary tract infections I Vasileiou, A Katsargyris, S Theocharis, C Giaginis Nutrition Research 33 (8), 595-607, 2013 | 145 | 2013 |
| Alternative measures of lipophilicity: From octanol-water partitioning to IAM retention C Giaginis, A Tsantili-Kakoulidou Journal of Pharmaceutical Sciences 97 (8), 2984-3004, 2008 | 140 | 2008 |
| Current state of the art in HPLC methodology for lipophilicity assessment of basic drugs. A review. C Giaginis, A Tsantili-Kakoulidou Journal of Liquid Chromatography & Related Technologies 31 (1), 79-96, 2007 | 134 | 2007 |
| MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. C Giaginis, S Vgenopoulou, P Vielh, S Theocharis Histology and histopathology 25 (3), 351-370, 2010 | 113 | 2010 |
| Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis? M Mantzorou, A Koutelidakis, S Theocharis, C Giaginis Nutrition and cancer 69 (8), 1151-1176, 2017 | 105 | 2017 |
| Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data M Mantzorou, E Pavlidou, G Vasios, E Tsagalioti, C Giaginis Phytotherapy Research 32 (6), 957-975, 2018 | 104 | 2018 |
| Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity C Giaginis, M Georgiadou, K Dimakopoulou, G Tsourouflis, E Gatzidou, ... Digestive diseases and sciences 54 (2), 282-291, 2009 | 104 | 2009 |
| Heat Shock Protein-27,-60 and-90 expression in gastric cancer: association with clinicopathological variables and patient survival C Giaginis, SS Daskalopoulou, S Vgenopoulou, I Sfiniadakis, G Kouraklis, ... BMC gastroenterology 9 (1), 1-10, 2009 | 101 | 2009 |
| NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links I Pateras, C Giaginis, C Tsigris, E Patsouris, S Theocharis Expert Opinion on Therapeutic Targets 18 (9), 1089-1101, 2014 | 85 | 2014 |
| MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker C Giaginis, A Giagini, G Tsourouflis, E Gatzidou, E Agapitos, G Kouraklis, ... Digestive diseases and sciences 56 (3), 777-785, 2011 | 83 | 2011 |
| Lipophilicity and biomimetic properties to support drug discovery F Tsopelas, C Giaginis, A Tsantili-Kakoulidou Expert opinion on drug discovery 12 (9), 885-896, 2017 | 79 | 2017 |
| Clinical significance of HuR expression in human malignancy I Kotta-Loizou, C Giaginis, S Theocharis Medical oncology 31 (9), 1-19, 2014 | 75 | 2014 |
| Current evidence on the anticancer potential of Chios mastic gum C Giaginis, S Theocharis Nutrition and cancer 63 (8), 1174-1184, 2011 | 75 | 2011 |
| Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands as potential therapeutic agents to treat arthritis C Giaginis, A Giagini, S Theocharis Pharmacological Research 60 (3), 60-69, 2009 | 72 | 2009 |
| Different retention behavior of structurally diverse basic and neutral drugs in immobilized artificial membrane and reversed-phase high performance liquid chromatography … D Vrakas, C Giaginis, A Tsantili-Kakoulidou Journal of Chromatogry A 1116 (1-2), 158-164, 2006 | 71 | 2006 |
| Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and … C Giaginis, N Tsoukalas, E Bournakis, P Alexandrou, N Kavantzas, ... BMC clinical pathology 14 (1), 1-12, 2014 | 68 | 2014 |
| Clinical significance of ephrin (eph)-A1,-A2,-a4,-a5 and-a7 receptors in pancreatic ductal adenocarcinoma C Giaginis, G Tsourouflis, A Zizi-Serbetzoglou, G Kouraklis, ... Pathology & Oncology Research 16 (2), 267-276, 2010 | 64 | 2010 |
| Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism C Giaginis, A Tsantili-Kakoulidou, S Theocharis Fundamental and Clinical Pharmacology 21 (3), 231-244, 2007 | 63 | 2007 |
| Epithelial–mesenchymal transition in non small-cell lung cancer N Tsoukalas, E Aravantinou-Fatorou, M Tolia, C Giaginis, ... Anticancer Research 37 (4), 1773-1778, 2017 | 61 | 2017 |
Anna Tsantili-KakoulidouNational andKaapodistrian University of AthensVerified email at pharm.uoa.gr
